Diasorin acquisition of luminex
WebFeb 13, 2024 · Acquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to provide full cell analysis solutions to its customers; transaction is in line with DiaSorin’s strategic priorities communicated to the market after Luminex acquisition WebFeb 13, 2024 · Transaction is in line with DiaSorin’s strategic priorities communicated to the market after Luminex acquisition; Employees associated with commercial, operations, …
Diasorin acquisition of luminex
Did you know?
WebApr 12, 2024 · The deal, which grows DiaSorin’s footprint in the key U.S. market, follows a similar acquisition by diagnostics rival Roche, which bought GenMark Diagnostics in a … WebNov 11, 2024 · 9M 2024 H IGHLIGHTS. B USINESS D EVELOPMENT . Completion of the acquisition of Luminex Corporation, a company that develops, manufactures, and sells proprietary biological testing technologies and products with leading applications throughout the Diagnostics and Life Science industries.The acquisition, completed on July 14, …
WebThe acquisition of Luminex Corporation represents an important step in the expansion strategy of DiaSorin ... DiaSorin Molecular LLC, a division of DiaSorin S.p.A., has received the Emergency Use Authorization (EUA) from the FDA for their Simplexa™ COVID-19 Direct kit. The kit provides a sample-to-answer test for the detection of severe acute ... WebDiaSorin announces completion of the acquisition of Luminex Corporation. The acquisition of Luminex Corporation represents an important step in the expansion …
WebApr 12, 2024 · The acquisition will broaden DiaSorin’s positioning in the molecular diagnostics space gaining access to Luminex’s molecular diagnostics multiplexing … WebMay 6, 2024 · Considering Luminex reported an EBITDA of just over $70M in 2024 (making the EV/EBITDA ratio of the deal based on a $1.8B acquisition cost approximately 25), …
WebApr 12, 2024 · April 12, 2024— DiaSorin has signed a definitive merger agreement to acquire Luminex for a total equity value of about $1.8 billion. Luminex, headquartered in Austin, Tex., develops, manufactures, and sells proprietary biological testing technologies and products throughout the diagnostics and life science industries. Through the …
WebApr 11, 2024 · Saluggia (Italy) - April 11, 2024 - DiaSorin S.p.A. ("DiaSorin"; FTSE MIB: DIA) today announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation ("Luminex"; NASDAQ: LMNX) for a price of USD 37.00 per share in an all-cash transaction. This … datatool s4 red replacementWebJul 15, 2024 · Diasorin on Wednesday completed the acquisition of Luminex Corp for $1.8 billion in a move aimed at boosting its molecular business and offset a potential drop in demand for COVID-19 tests as the ... bittersoet season 1 downloadWebApr 12, 2024 · Yesterday’s debt-fuelled purchase of Luminex by Diasorin is, at $1.8bn, tied with Roche’s takeout of Genmark Diagnostics as the biggest acquisition of a Covid-19 test developer so far this year. But the buyers also have suites of Covid-19 assays of their own. Drowning in cash as a result, the big guns have their pick of acquisition targets ... data tools generatefnis_for_usersWebApr 13, 2024 · Written by Zacks Equity Research for Zacks ->. Luminex Corporation LMNX is set to be acquired by the Italian diagnostics company DiaSorin S.p.A. for a price of $37 per share or approximately $1.8 ... datatools cowbridge roadWeb2 days ago · Similarly, DiaSorin completed its acquisition of Luminex Corporation in August 2024, while Kehua-Bio-Engineering acquired Jingcheng Medical in the same … bittersoet english subtitles episodes nihanWebFeb 25, 2024 · Italian diagnostics company DiaSorin SpA is considering an acquisition of rival Covid-19 testing-kit maker Luminex Corp., according to people familiar with the … bittersoet new seasonWebJul 15, 2024 · With 900 clients, Luminex develops biological testing technologies. Credit: Darko Stojanovic from Pixabay. Italian diagnostics firm DiaSorin has concluded the acquisition of Luminex in an all-cash … bittersoet season 2 finale